Cost comparison of three treatments for localized prostate cancer in Spain: Radical prostatectomy, prostate brachytherapy and external 3D conformal radiotherapy;Comparación de costes de tres tratamientos del cáncer de próstata localizadoen España: prostatectomía radical, braquiterapia prostáticay radioterapia conformacional externa 3D

Gaceta Sanitaria

Volumn 25, Issue 1, 2011, Pages 35-43

  Becerra Bachino, Virginia ^a   Cots, Francesc ^b,c   Guedea, Ferran ^d   Pera, Joan ^d   Boladeras, Ana ^d   Aguiló, Ferran ^e   Suárez, José Francisco ^e   Gallo, Pedro ^c,f   Murgui, Lluis ^e,f   Pont, Àngels ^a   Cunillera, Oriol ^a   Pardo, Yolanda ^a   Ferrer, Montserrat ^a,c,g  

^a HOSPITAL DEL MAR   (Spain)

^b Del Mar University   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^e HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^f UNIVERSITY OF BARCELONA   (Spain)

^g UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Brachytherapy; Costs; Prostate cancer; Prostatectomy; Radiotherapy

Indexed keywords

RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

ADENOCARCINOMA; AGED; ARTICLE; BRACHYTHERAPY; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; COST; ECONOMICS; HEALTH CARE COST; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; NONPARAMETRIC TEST; PROSPECTIVE STUDY; PROSTATE TUMOR; PROSTATECTOMY; REGRESSION ANALYSIS; SOCIOECONOMICS; STATISTICS;

ADENOCARCINOMA; AGED; BRACHYTHERAPY; COSTS AND COST ANALYSIS; DIRECT SERVICE COSTS; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; RADIOTHERAPY, CONFORMAL; REGRESSION ANALYSIS; SOCIOECONOMIC FACTORS; STATISTICS, NONPARAMETRIC;

EID: 79952190073     PISSN: 02139111     EISSN: 15781283     Source Type: Journal    
DOI: 10.1016/j.gaceta.2010.10.008     Document Type: Article

References (30)

1. Ferlay J., Autier P., Boniol M., et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007, 18:581-592.
2. Shao Y.H., Demissie K., Shih W., et al. Contemporary risk profile of prostate cancer in the United States. J Natl Cancer Inst. 2009, 101:1280-1283.
3. Brown M.L., Riley G.F., Schussler N., et al. Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care. 2002, 40. IV-17.
4. Antoñanzas-Villar FJ, Oliva J, Velasco M, et al. Costes directos e indirectos del cáncer en España. Cuadernos económicos de ICE (Ejemplar dedicado a: Decisiones de inversión y adopción de nuevas tecnologías. Raouf Boucekkine, Luis A. Puch, coord.). 2006; pp. 281-309.
5. Mullins C.D., Snyder S.E., Wang J., et al. Economic disparities in treatment costs among ambulatory Medicaid cancer patients. J Natl Med Assoc. 2004, 96:1565-1574.
6. Norderhaug I., Dahl O., Hoisaeter P.A., et al. Brachytherapy for prostate cancer: a systematic review of clinical and cost effectiveness. Eur Urol. 2003, 44:40-46.
7. Poon I., Pintilie M., Potvin M., et al. The changing costs of radiation treatment for early prostate cancer in Ontario: a comparison between conventional and conformal external beam radiotherapy. Can J Urol. 2004, 11:2125-2132.
8. Anderson J.K., Murdock A., Cadeddu J.A., et al. Cost comparison of laparoscopic versus radical retropubic prostatectomy. Urology. 2005, 66:557-560.
9. Ciezki J.P., Klein E.A., Angermeier K.W., et al. Cost comparison of radical prostatectomy and transperineal brachytherapy for localized prostate cancer. Urology. 2000, 55:68-72.
10. Buron C., Le Vu B., Cosset J.M., et al. Brachytherapy versus prostatectomy in localized prostate cancer: results of a French multicenter prospective medico-economic study. Int J Radiat Oncol Biol Phys. 2007, 67:812-822.
11. Hummel S, Paisley S, Morgan A, et al. Clinical and cost-effectiveness of new and emerging technologies for early localised prostate cancer: a systematic review. Health Technol Assess. 2003; 7:iii, ix-iii,157.
12. Wagner T.T., Young D., Bahnson R.R. Charge and length of hospital stay analysis of radical retropubic prostatectomy and transperineal prostate brachytherapy. J Urol. 1999, 161:1216-1218.
13. Wilson L.S., Tesoro R., Elkin E.P., et al. Cumulative cost pattern comparison of prostate cancer treatments. Cancer. 2007, 109:518-527.
14. Taplin S.H., Barlow W., Urban N., et al. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst. 1995, 87:417-426.
15. Sabes R, Escalona S, Blasco JA, et al. Crioterapia en cáncer de próstata: estimación de costes hospitalarios y comparación respecto a prostatectomía radical en la Comunidad de Madrid. XXV Jornadas de Economía de la Salud: Economía de la salud, ¿dónde estamos 25 años después? Barcelona, 13-15 julio; 2005.
16. García-Altes A., Jovell A.J. Could we measure the efficiency of prostate cancer treatment? A critical appraisal of economic evaluation studies. Prostate Cancer Prostatic Dis. 2001, 4:217-220.
17. Ferrer M., Suárez J.F., Guedea F., et al. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008, 72:421-432.
18. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998, 280:969-974.
19. National Collaborating Centre for Cancer. NICE clinical guideline 58. Prostate Cancer: diagnosis and treatment; 2008.
20. Halvorsen R., Palmquist R. The interpretation of dummy variables in semilogarithmic equation. Am Econ Rev. 1980, 70:474-475.
21. Brandeis J., Pashos C.L., Henning J.M., et al. A nationwide charge comparison of the principal treatments for early stage prostate carcinoma. Cancer. 2000, 89:1792-1799.
22. Bauvin E., Molinier L., Dervaux B., et al. [Cost and efficacy of treatment strategies in localized prostatic cancer: feasibility study in the general population]. Prog Urol. 2003, 13:618-623.
23. Mason A, Epstein D, Smith P, et al. Final report. International comparison of costs: an exploration of within- and between-country variations for ten healthcare services in nine EU member states. Deliverable 34, Phase III, Work Package 10 (WP10); 2007.
24. Busse R., Schreyogg J., Smith P.C. Variability in healthcare treatment costs amongst nine EU countries - results from the HealthBASKET project. Health Econ. 2008, 17:S1-S8.
25. Espinas JA, Corral J, Cots F, et al. Costes en la gestión de oncología radioterápica. I Congreso Internacional de La Rioja sobre nuevas tácticas y técnicas en oncología radioterápica. 22-23 mayo 2008; Logroño, España. (Consultado 27/5/2009.) Disponible en: http://congresorioja.riojasalud.es/ficheros/sgestion/1.pdf.
26. Ploquin N.P., Dunscombe P.B. The cost of radiation therapy. Radiother Oncol. 2008, 86:217-223.
27. Stokes S.H. Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation. Int J Radiat Oncol Biol Phys. 2000, 47:129-136.
28. Stone P.W., Chapman R.H., Sandberg E.A., et al. Measuring costs in cost-utility analyses. Variations in the literature. Int J Technol Assess Health Care. 2000, 16:111-124.
29. Oliva J., Del Llano J., Sacristan J.A. [Análisis de las evaluaciones económicas de tecnologías sanitarias realizadas en España en la década 1990-2000.]. Gac Sanit. 2002, 16(Suppl 2):2-11.
30. Pritchard C., Sculpher M. Productivity costs: principles and practice in economic evaluation 2000, Office of Health Economics, London.